A Stress-Induced Vicious Cycle In The Development of T1D
A Stress-Induced Vicious Cycle In The Development of T1D
批准号:
10262964
负责人:
PETER ARVAN
金额:
$70.36万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-15 至 2024-06-30
关键词:
ATF6 geneAccelerationAddressAffectAmericanApoptosisApplications GrantsAutoimmunityAutomobile DrivingB-Cell DevelopmentBeta CellBiochemicalBiological AssayC-PeptideCalciumCell DeathCell SurvivalCell physiologyCoupledDataDefectDevelopmentDiabetes MellitusDiseaseEndoplasmic ReticulumEnvironmental Risk FactorEnzymesEventFailureFunctional disorderFutureGenerationsGeneticHomeostasisHumanITPR1 geneImmune systemImpairmentIn VitroInflammationInflammatoryInsulinInsulin-Dependent Diabetes MellitusIntentionIslets of LangerhansLaboratoriesLeadLinkMeasurementMediatingMembraneMembrane ProteinsMetabolismMitochondriaModelingNatureNeurodegenerative DisordersOptical reporterPancreasPathway interactionsPatientsPeptide Signal SequencesPeptidesPharmacologyPhasePhosphorylationPredisposing FactorProcessProinsulinProteinsRequest for ApplicationsRespirationRoleSignal TransductionSiteStimulusStressStress Response SignalingStructure of beta Cell of isletTestingTransplantationUbiquitinVariantWestern BlottingWorkXenograft Modelautoimmune pathogenesisbiological adaptation to stressblood glucose regulationcell injurycohesioncytokineeffector T cellendoplasmic reticulum stressexhaustiongenetic approachin vivoin vivo Modelinsulin dependent diabetes mellitus onsetinsulin secretionisletislet xenograftmitochondrial metabolismneoantigensnovelpreproinsulinpreservationpreventprotein foldingresponsestress kinasetherapeutically effectivetranslation factortrigger pointubiquitin ligaseubiquitin-protein ligase
中文摘要
点击翻译按钮获取中文摘要
英文摘要
A VICIOUS CYCLE OF (PRE)PROINSULIN-MEDIATED ER STRESS, UBIQUITIN-LIGASE ACTIVATION,
and DISORDERED Ca2+-HANDLING IN PANCREATIC BETA CELLS
This proposal is submitted in response to a request-for-applications for Discovery of Early Type 1 Diabetes
Disease Processes in the Human Pancreas (including the possibility of studies of signaling/processing
pathways that are dysregulated in stressed beta cells during the asymptomatic phase of T1D). Our
group of three pancreatic beta cell biologists with distinct expertise (Drs. Arvan, Soleimanpour, and
Satin) brings forward a novel hypothesis about the initiating beta cell events in T1D, with the realization that
these intricacies exceed what any one laboratory could exhaustively study on their own. Specifically, the three
collaborating P.I.s propose a chain of beta cell defects that can be initiated and exacerbated by pro-
inflammatory stimuli but are then further propagated by a failure of inter-organellar support, including the
endoplasmic reticulum (ER) and mitochondria. It is well known that activation of ER stress signaling upon
perturbation of ER homeostasis (launched from multiple potential initiators, including proinflammatory
cytokines) triggers activation of stress kinases that include (but are not limited to) the ER membrane protein,
PERK. New evidence suggests that ER stress kinase activity results in phosphorylation (and thereby
activation) of one or more E3 ubiquitin (Ub) ligases residing at ER-mitochondrial contact sites known as MAMs.
We posit that ER stress-related E3 Ub-ligase activation stimulates ubiquitylation and proteasomal turnover of a
number of MAM resident proteins including the well-recognized mitochondrial substrate, mitofusin-2, but also
key components of ER-to-mitochondrial Ca2+ transfer including IP3R1 and others. ER stress-provoked
degradation of MAM protein components can be evaluated biochemically and quantitatively by Western
blotting; but we go beyond this to examine the functional consequences via measurements of impaired ER-to-
mitochondrial Ca2+ transfer. We propose that such calcium imbalance further impairs mitochondrial function
including (but not limited to) impaired ATP generation, which exacerbates the perturbation of ER homeostasis
with concomitant ER stress. In short, we propose that pro-inflammatory triggers of T1D can initiate a
vicious cycle leading to beta cell failure. This hypothesis will be tested in human islets in vitro as well as in
an in vivo model involving transplanted human islets. Finally, we propose to probe certain trigger points to
break the vicious cycle, in an attempt to rescue beta cell survival and function, with the intention of preventing
T1D onset and progression.
1
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Improving Proinsulin Folding to Ameliorate Type II Diabetes
-
批准号:10657292
-
项目类别:
-
资助金额:$80.96万
-
财政年份:2023
-
负责人:PETER ARVAN
-
依托单位:
Endoplasmic Reticulum stress and thyroid cell death
-
批准号:10595662
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2022
-
负责人:PETER ARVAN
-
依托单位:
Endoplasmic Reticulum stress and thyroid cell death
-
批准号:10414536
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2022
-
负责人:PETER ARVAN
-
依托单位:
A Stress-Induced Vicious Cycle In The Development of T1D
-
批准号:10653099
-
项目类别:
-
资助金额:$70.36万
-
财政年份:2020
-
负责人:PETER ARVAN
-
依托单位:
A Stress-Induced Vicious Cycle In The Development of T1D
-
批准号:10440524
-
项目类别:
-
资助金额:$70.36万
-
财政年份:2020
-
负责人:PETER ARVAN
-
依托单位:
Interplay Between SERPINB1 and TLR2/TLR4 in Beta Cell Regeneration
-
批准号:10531213
-
项目类别:
-
资助金额:$49.9万
-
财政年份:2018
-
负责人:PETER ARVAN
-
依托单位:
Secretory Pathway Protein Degradation Maintains Insulin Biogenesis + Secretion
-
批准号:10647830
-
项目类别:
-
资助金额:$63.69万
-
财政年份:2016
-
负责人:PETER ARVAN
-
依托单位:
Secretory Pathway Protein Degradation Maintains Insulin Biogenesis + Secretion
-
批准号:10217112
-
项目类别:
-
资助金额:$63.69万
-
财政年份:2016
-
负责人:PETER ARVAN
-
依托单位:
Secretory Pathway Protein Degradation Maintains Insulin Biogenesis + Secretion
-
批准号:10430023
-
项目类别:
-
资助金额:$63.69万
-
财政年份:2016
-
负责人:PETER ARVAN
-
依托单位:
Modifiers of Proinsulin Influence T2D Susceptibility
-
批准号:9351508
-
项目类别:
-
资助金额:$100.88万
-
财政年份:2016
-
负责人:PETER ARVAN
-
依托单位:
Multidisciplinary Training Program in Basic Diabetes Research
-
批准号:10244911
-
项目类别:
-
资助金额:$35.4万
-
财政年份:2014
-
负责人:PETER ARVAN
-
依托单位:
Multidisciplinary Training Program in Basic Diabetes Research
-
批准号:10686283
-
项目类别:
-
资助金额:$36.92万
-
财政年份:2014
-
负责人:PETER ARVAN
-
依托单位:
Multidisciplinary Training Program in Basic Diabetes Research
-
批准号:10596892
-
项目类别:
-
资助金额:$5.51万
-
财政年份:2014
-
负责人:PETER ARVAN
-
依托单位:
Multidisciplinary Training Program in Basic Diabetes Research
-
批准号:10466930
-
项目类别:
-
资助金额:$33.08万
-
财政年份:2014
-
负责人:PETER ARVAN
-
依托单位:
Peptide Hormone Sorting to the Secretory/Storage Granule
-
批准号:8003256
-
项目类别:
-
资助金额:$2.25万
-
财政年份:2009
-
负责人:PETER ARVAN
-
依托单位:
Thyrocyte Protein Transport to the Cell Surface
-
批准号:8003365
-
项目类别:
-
资助金额:$7.74万
-
财政年份:2009
-
负责人:PETER ARVAN
-
依托单位:
How mutations in proinsulin cause diabetes: a protein-misfolding disease
-
批准号:8448597
-
项目类别:
-
资助金额:$44.35万
-
财政年份:2004
-
负责人:PETER ARVAN
-
依托单位:
How mutations in proinsulin cause diabetes: a protein-misfolding disease
-
批准号:8132181
-
项目类别:
-
资助金额:$58.88万
-
财政年份:2004
-
负责人:PETER ARVAN
-
依托单位:
How mutations in proinsulin cause diabetes: a protein-misfolding disease
-
批准号:8640155
-
项目类别:
-
资助金额:$45.85万
-
财政年份:2004
-
负责人:PETER ARVAN
-
依托单位:
How mutations in proinsulin cause diabetes: a protein-misfolding disease
-
批准号:8249808
-
项目类别:
-
资助金额:$46.07万
-
财政年份:2004
-
负责人:PETER ARVAN
-
依托单位:
海外基金